<p>Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B</p>
Caixia Zheng(First Affiliated Hospital of Xiamen University), Xiaolu Wu(First Affiliated Hospital of Xiamen University), Hong‐Hong Yan(Sun Yat-sen University), Jianyong Zeng(First Affiliated Hospital of Xiamen University), Shaohang Cai(Key Laboratory of Guangdong Province)
Cited by 34
Related Papers
Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling
|Cancer Research|2021|127
<i>Retracted:</i><scp>HB</scp>x‐mediated decrease of <scp>AIM</scp>2 contributes to hepatocellular carcinoma metastasis
|Molecular Oncology|2017|92
Association Between Clinical Manifestations and Prognosis in Patients with COVID-19
|Clinical Therapeutics|2020|84
Association between obesity and clinical prognosis in patients infected with SARS-CoV-2
|Infectious Diseases of Poverty|2020|84
Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study
|Journal for ImmunoTherapy of Cancer|2020|63